These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1896960)

  • 1. Heparin cofactor II significance for the inhibition of thrombin at the injured vessel wall.
    Pasche B; Swedenborg J; Frebelius S; Olsson P
    Thromb Res; 1991 Jun; 62(5):409-19. PubMed ID: 1896960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depolymerized holothurian glycosaminoglycan with novel anticoagulant actions: antithrombin III- and heparin cofactor II-independent inhibition of factor X activation by factor IXa-factor VIIIa complex and heparin cofactor II-dependent inhibition of thrombin.
    Nagase H; Enjyoji K; Minamiguchi K; Kitazato KT; Kitazato K; Saito H; Kato H
    Blood; 1995 Mar; 85(6):1527-34. PubMed ID: 7888673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of thrombin with heparin cofactor II and antithrombin III on prostacyclin production by cultured endothelial cells.
    Kaji T; Itoh F; Hayakawa Y; Oguma Y; Sakuragawa N
    Thromb Res; 1989 Oct; 56(1):99-107. PubMed ID: 2512688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of thrombus formation and growth by antithrombin III and heparin cofactor II-dependent thrombin inhibitors: importance of heparin cofactor II.
    Buchanan MR; Liao P; Smith LJ; Ofosu FA
    Thromb Res; 1994 Jun; 74(5):463-75. PubMed ID: 8085247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombogenicity of the injured vessel wall--role of antithrombin and heparin.
    Frebelius S; Hedin U; Swedenborg J
    Thromb Haemost; 1994 Jan; 71(1):147-53. PubMed ID: 8165634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coagulant and noncoagulant thrombin enzymatic activity on the endothelium.
    Frebelius S; Nydahl S; Swedenborg J
    Blood Coagul Fibrinolysis; 1990 Aug; 1(3):285-92. PubMed ID: 2103313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of heparin cofactor II on thrombin-stimulated prostacyclin production by cultured vascular smooth muscle cells.
    Hayashi T; Kaji T; Hayakawa Y; Niiya K; Sakamoto M; Sakuragawa N
    Thromb Res; 1991 Nov; 64(3):321-30. PubMed ID: 1805447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of thrombin on subendothelium. Studies on rabbit aorta, ex vivo.
    Nydahl S; Frebelius S; Swedenborg J
    Eur Surg Res; 1989; 21(5):287-95. PubMed ID: 2627983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of a thrombin anion-binding exosite-2 mutant by the glycosaminoglycan-dependent serpins protein C inhibitor and heparin cofactor II.
    Cooper ST; Rezaie AR; Esmon CT; Church FC
    Thromb Res; 2002 Jul; 107(1-2):67-73. PubMed ID: 12413592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of high levels of heparin cofactor II in the plasma and urine of adult patients with nephrotic syndrome.
    Toulon P; Gandrille S; Remy P; Chadeuf G; Jouvin MH; Aiach M
    Nephron; 1992; 60(2):176-80. PubMed ID: 1553002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural features of heparin and their effect on heparin cofactor II mediated inhibition of thrombin.
    Kim YS; Linhardt RJ
    Thromb Res; 1989 Jan; 53(1):55-71. PubMed ID: 2922702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased heparin cofactor II activity is associated with impaired endothelial function determined by brachial ultrasonography and predicts cardiovascular events.
    Huang PH; Leu HB; Chen JW; Wu TC; Lu TM; Yu-An Ding P; Lin SJ
    Int J Cardiol; 2007 Jan; 114(2):152-8. PubMed ID: 16650906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombin inhibition by antithrombin III on the subendothelium is explained by the isoform AT beta.
    Frebelius S; Isaksson S; Swedenborg J
    Arterioscler Thromb Vasc Biol; 1996 Oct; 16(10):1292-7. PubMed ID: 8857927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uptake of heparin cofactor II and antithrombin into the aorta wall after a deendothelializing injury in vivo: comparison with the behaviors of prothrombin and fibrinogen.
    Hatton MW; Ross B; Southward SM; Dereske M; Hoogendoorn H; Blajchman MA; Richardson M
    J Lab Clin Med; 1999 Jan; 133(1):81-7. PubMed ID: 10385486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombin action of phosvitin and other phosphate-containing polyanions is mediated by heparin cofactor II.
    Church FC; Pratt CW; Treanor RE; Whinna HC
    FEBS Lett; 1988 Sep; 237(1-2):26-30. PubMed ID: 3169238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutagenesis of thrombin selectively modulates inhibition by serpins heparin cofactor II and antithrombin III. Interaction with the anion-binding exosite determines heparin cofactor II specificity.
    Sheehan JP; Wu Q; Tollefsen DM; Sadler JE
    J Biol Chem; 1993 Feb; 268(5):3639-45. PubMed ID: 8429040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombin-inhibitory capacity of the injured vessel wall.
    Pasche B; Swedenborg J; Hedin U; Olsson P; Ljungqvist A
    Thromb Res; 1991 Jun; 62(5):531-44. PubMed ID: 1832792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of thrombin anion-binding exosite-I in the formation of thrombin-serpin complexes.
    Myles T; Church FC; Whinna HC; Monard D; Stone SR
    J Biol Chem; 1998 Nov; 273(47):31203-8. PubMed ID: 9813026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective and sustained inhibition of surface-bound thrombin activity by intimatan/heparin cofactor II and its relevance to assessing systemic anticoagulation in vivo, ex vivo and in vitro.
    Buchanan MR; Maclean GA; Brister SJ
    Thromb Haemost; 2001 Sep; 86(3):909-13. PubMed ID: 11583326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A rationale for targeting antithrombotic therapy at the vessel wall: improved antithrombotic effect and decreased risk of bleeding.
    Buchanan MR; Brister SJ
    Wien Klin Wochenschr; 1999 Feb; 111(3):81-9. PubMed ID: 10093889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.